Published in J Mol Cell Cardiol on October 22, 2007
Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol (2012) 2.24
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome. Int J Proteomics (2012) 1.36
Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol (2008) 1.22
Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol (2011) 1.11
The role of the proteasome in heart disease. Biochim Biophys Acta (2010) 0.99
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology (2014) 0.94
The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci (2012) 0.93
Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med (2008) 0.92
The ubiquitin-proteasome system in myocardial ischaemia and preconditioning. Cardiovasc Res (2009) 0.91
The ubiquitin proteasome system and myocardial ischemia. Am J Physiol Heart Circ Physiol (2012) 0.90
Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells. Mol Cell Neurosci (2011) 0.85
Proteome dynamics and proteome function of cardiac 19S proteasomes. Mol Cell Proteomics (2011) 0.81
Integrated microRNA and mRNA responses to acute human left ventricular ischemia. Physiol Genomics (2015) 0.81
Cardiac protection by preconditioning is generated via an iron-signal created by proteasomal degradation of iron proteins. PLoS One (2012) 0.80
Adaptation to chronic continuous hypoxia potentiates Akt/HK2 anti-apoptotic pathway during brief myocardial ischemia/reperfusion insult. Mol Cell Biochem (2017) 0.75
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol (2004) 1.93
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med (2007) 1.90
Retracted Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2006) 1.77
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. J Pharmacol Exp Ther (2006) 1.71
Retracted Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol (2006) 1.70
Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets (2007) 1.63
Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways. J Pharmacol Exp Ther (2005) 1.62
Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation (2004) 1.58
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res (2008) 1.55
Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med (2008) 1.54
Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res (2003) 1.53
Retracted Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol. J Cell Mol Med (2006) 1.50
Retracted Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium. J Cell Mol Med (2007) 1.48
Redox signaling in vascular angiogenesis. Free Radic Biol Med (2002) 1.45
Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal (2005) 1.40
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res (2009) 1.40
Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol (2009) 1.32
Resveratrol and chemoprevention. Cancer Lett (2009) 1.31
Retracted Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem (2008) 1.31
Autophagy, redox signaling, and ventricular remodeling. Antioxid Redox Signal (2009) 1.28
Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr (2002) 1.26
Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov (2007) 1.24
Molecular mechanism of preconditioning. IUBMB Life (2008) 1.23
Retracted Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med (2008) 1.22
Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med (2008) 1.21
Cardioprotection by endoplasmic reticulum stress-induced autophagy. Antioxid Redox Signal (2011) 1.21
Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One (2010) 1.17
Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol (2005) 1.16
Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol (2003) 1.13
Retracted Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.13
Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys (2006) 1.12
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta (2008) 1.11
Dose-dependency of resveratrol in providing health benefits. Dose Response (2010) 1.11
Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol (2007) 1.11
Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci (2011) 1.10
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol (2007) 1.10
Retracted Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res (2006) 1.09
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol (2004) 1.09
Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal (2009) 1.08
Retracted Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol (2005) 1.08
GATA-4 regulation of myocardial survival in the preconditioned heart. J Mol Cell Cardiol (2004) 1.08
Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J (2003) 1.08
STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am J Physiol Heart Circ Physiol (2003) 1.07
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol (2002) 1.06
Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann N Y Acad Sci (2002) 1.05
Retracted Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol (2007) 1.05
Retracted Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J Mol Cell Cardiol (2007) 1.03
MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury. J Mol Cell Cardiol (2004) 1.03
Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats. J Am Assoc Lab Anim Sci (2007) 1.01
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am J Physiol Heart Circ Physiol (2007) 1.01
BAG-1 induces autophagy for cardiac cell survival. Autophagy (2009) 1.00
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res (2011) 0.97
Retracted Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem (2007) 0.96
Retracted Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol (2007) 0.96
Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol (2010) 0.95
Potential candidates for ischemic preconditioning-associated vascular growth pathways revealed by antibody array. Am J Physiol Heart Circ Physiol (2005) 0.95
Retracted Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol. J Agric Food Chem (2008) 0.94
Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta (2008) 0.94
Resveratrol and cardiovascular health. Mol Aspects Med (2010) 0.94
Neem leaf glycoprotein directs T-bet-associated type 1 immune commitment. Hum Immunol (2008) 0.94
Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts. J Mol Cell Cardiol (2005) 0.94
Retracted Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic Biol Med (2007) 0.94
Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem (2003) 0.94
Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection. J Cell Mol Med (2010) 0.94
Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling. J Immunother (2009) 0.92
Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. J Cell Mol Med (2012) 0.92
Retracted Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid Redox Signal (2006) 0.92
Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol (2002) 0.92
Retracted Role of glutaredoxin-1 in cardioprotection: an insight with Glrx1 transgenic and knockout animals. J Mol Cell Cardiol (2007) 0.91
Role of ceramide in ischemic preconditioning. J Am Coll Surg (2004) 0.91
MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y Acad Sci (2011) 0.90
The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res (2009) 0.90
Retracted Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling. Antioxid Redox Signal (2007) 0.90
Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation. Vaccine (2008) 0.90
Physiological effects of resveratrol. Biofactors (2010) 0.90
Autophagy in the myocardium: Dying for survival? Exp Clin Cardiol (2006) 0.89
Cardioprotection with grapes. J Cardiovasc Pharmacol (2002) 0.89
Role of reactive oxygen species in the development of cytotoxicity with various forms of chewing tobacco and pan masala. Toxicology (2002) 0.89
Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic Biol Med (2007) 0.89
Lipid raft in cardiac health and disease. Curr Cardiol Rev (2009) 0.89
Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium. J Cell Mol Med (2010) 0.88
Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. Can J Physiol Pharmacol (2010) 0.88
Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem (2008) 0.88
Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci (2002) 0.88
Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart. J Mol Cell Cardiol (2006) 0.87
Essential role of lipid raft in ischemic preconditioning. Cell Physiol Biochem (2008) 0.87
Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease. Ann Med (2011) 0.87
Longevity nutrients resveratrol, wines and grapes. Genes Nutr (2009) 0.87
Angiotensin preconditioning of the heart: evidence for redox signaling. Cell Biochem Biophys (2006) 0.87
Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics. Mol Cell Biochem (2011) 0.87